Correlation Between Molecular Partners and Oric Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Oric Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Oric Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Oric Pharmaceuticals, you can compare the effects of market volatilities on Molecular Partners and Oric Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Oric Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Oric Pharmaceuticals.
Diversification Opportunities for Molecular Partners and Oric Pharmaceuticals
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Molecular and Oric is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Oric Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oric Pharmaceuticals and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Oric Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oric Pharmaceuticals has no effect on the direction of Molecular Partners i.e., Molecular Partners and Oric Pharmaceuticals go up and down completely randomly.
Pair Corralation between Molecular Partners and Oric Pharmaceuticals
Given the investment horizon of 90 days Molecular Partners AG is expected to under-perform the Oric Pharmaceuticals. In addition to that, Molecular Partners is 1.4 times more volatile than Oric Pharmaceuticals. It trades about -0.07 of its total potential returns per unit of risk. Oric Pharmaceuticals is currently generating about 0.18 per unit of volatility. If you would invest 845.00 in Oric Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 135.00 from holding Oric Pharmaceuticals or generate 15.98% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. Oric Pharmaceuticals
Performance |
| Timeline |
| Molecular Partners |
| Oric Pharmaceuticals |
Molecular Partners and Oric Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Oric Pharmaceuticals
The main advantage of trading using opposite Molecular Partners and Oric Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Oric Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oric Pharmaceuticals will offset losses from the drop in Oric Pharmaceuticals' long position.| Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
| Oric Pharmaceuticals vs. Seer Inc | Oric Pharmaceuticals vs. Anebulo Pharmaceuticals | Oric Pharmaceuticals vs. Cullinan Oncology LLC | Oric Pharmaceuticals vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |